The aim of this study is to evaluate and compare mothers' and grandparents' feeding behaviours, the differences between the behaviours, the relationship between children's feeding problems and grandparents' feeding behaviours, as well as the relationship between grandparents' feeding behaviour and children's body mass index (BMI). This study prompts physicians to pay attention to the on feeding behaviours of grandmothers when evaluating the feeding problems and behaviours of children. This study is a controlled case study. Two hundred children (between 2 and 5 years of age) were included. Amongst these children, 150 of them were only fed by their mothers and 50 of them were fed by both their mother and grandmother. The feeding behaviour was evaluated by the Comprehensive Feeding Practices Questionnaire (CFPQ).Three domains emerged in this study: Some of the feeding behaviours were significantly different between the mothers and grandmothers who were questioned in the CFPQ. The feeding behaviours are related to the feeding problems; in this study, we show that, in some cases, whether some feeding behaviours were applied either more or less had a significant influence on feeding problems. There were positive correlations between the feeding behaviours of mothers and grandmothers. Conclusion: There is limited research about grandmothers' influence on child feeding. Research in grandmothers' feeding behaviours may reveal key concerns in children feeding problems and in preventing childhood obesity. What is Known: • According to studies, there are differences between the feeding behaviours of mothers and grandmothers. What is New: • This study is the first to explore the relationship between the feeding problems and feeding behaviours of both mothers and grandmothers. Also, a comparison of the mothers' and fathers' mothers' feeding behaviours has not yet been carried out.

To the Editor, The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe, and the World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) a pandemic in mid-March of 2020. In the pediatric age group, symptomatic COVID-19 has been mostly reported in children with inborn errors of immunity (IEI), chronic lung disease, and heart disease. 1 Patients with IEI can be expected to have more severe illness. Moreover, due to weak cellular immunity and viral control, more severe disease is expected in patients with combined immunodeficiencies than in those with humoral defects. 2 However, other authors have proposed that the opposite may be expected in immunocompromised patients. In children with IEI, the lack of the pro-inflammatory cytokine storm implicated in the pathogenesis of severe COVID-19 may protect these patients from multiple organ failure. 3 Therefore, we aimed to determine the incidence and clinical severity of COVID-19 in IEI patients under follow-up in our hospital. Patients who were followed up or newly diagnosed with IEI in our clinic between September 1, 2019, and October 1, 2020, were included in the study. The patients' parents were called and asked whether the patient had COVID-19 or had contact with anyone with COVID-19. The patients' results from viral tests including reverse transcription-polymerase chain reaction (RT-PCR) of a nasopharyngeal sample and IgM/IgG antibody testing for SARS-CoV-2 were recorded. Indications for hospitalization and treatment were determined based on the pediatric patient management and treatment guide from the Turkish Ministry of Health.

<b><i>Introduction:</i></b> There are a limited number of studies about the clinical findings of coronavirus infection in pediatric patients with asthma. We aimed to evaluate the clinical and laboratory characteristics of pediatric patients with asthma and healthy children without chronic disease who infected with SARS-CoV-2. <b><i>Methods:</i></b> This is a retrospective, case-control study comparing the asthma diagnosed and healthy children who were diagnosed as COVID-19 in our hospital between March 11 and November 10, 2020. <b><i>Results:</i></b> During the study period, 6,205 children were diagnosed with CO­VID-19 in our hospital. Only 54 (0.87%) patients had a diagnosis of asthma. The mean of the age was 10.5 years and 53.7% (<i>n</i>:29) of the patients with asthma were male. Cough, shortness of breath, emesis, and diarrhea were found to be significantly higher in asthma group than in the control group (respectively <i>p</i> = 0.002, 0.000, 0.002, 0.019, 0.015). Patients who were given SABA was significantly higher in asthma diagnosed patients (<i>p</i> = 0.000). Hospitalization was significantly higher in asthma group (<i>p</i> = 0.025), and the duration of hospitalization was significantly higher in control group (<i>p</i> = 0.034). There was no significant difference between the 2 groups in terms of requiring oxygen treatment and in laboratory findings between groups. <b><i>Conclusion:</i></b> This study revealed that pediatric patients diagnosed with asthma were in a mild clinic. According to these findings, asthma may not affect the course of the COVID-19 in children.

Background: Cat allergen is among the most common household allergens and can cause respiratory allergies and anaphylaxis in children. Objective: The aim of this study was to evaluate the characteristics of cat allergies in children and the impact of the coronavirus disease 2019 (COVID-19) pandemic on these characteristics. Methods: The study included pediatric patients with cat allergen sensitization demonstrated by skin-prick test (SPT) over a period of 2 years: 1 year before and 1 year during the pandemic. Demographic data, clinical features, and laboratory findings were evaluated from the patients' records. Results: Of 7428 SPTs performed, 566 patients (7.6%) were sensitized to cat allergen (56% boys; median age, 11 years). Fifty-eight percent of the patients (n = 329) presented during the pandemic period, 44.5% (n = 252) had symptoms with cat exposure, and 9% (n = 51/566) had anaphylaxis. Allergic rhinitis and asthma were present in 76% (n = 431) and 46.6% (n = 264) of the patients, respectively. When compared to prepandemic period, patients who presented during the pandemic had higher rates of cat sensitization (15% in pandemic group versus 4.4% in prepandemic group of all SPTs performed; p < 0.05), cat ownership (29.1% versus 13.9%; p < 0.001), and symptoms on cat exposure (51% versus 34%; p < 0.001). Factors that predicted symptom development in the patients who were cat sensitized were induration > 5 mm on SPT (odds ratio [OR] 1.9 [95% confidence interval {95% CI}], 1.1‐3.2), cat ownership (OR 9.2 [95% CI, 4.9‐17.3]), close contact with a cat owner (OR 7.1 [95% CI, 4‐12]), allergic rhinitis (OR 3.1 [95% CI, 1.6‐5.8]), conjunctivitis (OR 4.7 [95% CI, 2‐10]), and atopic dermatitis (OR 2.2 [95% CI, 1‐4.7]). Conclusion: We observed an increase in the prevalence of cat allergy among children during the COVID-19 pandemic. Care must be taken in terms of anaphylaxis in patients who were cat sensitized.

No abstract